Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betamethasone for neonatal outcomes in term small-for-gestational-age pregnancies
IRCT20250227064870N1Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- May 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of betamethasone in Small for gestational age (SGA) (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoints: First minute Apgar score and Fifth minute Apgar score. Started May 2025; status: completed.
02
Drugs
betamethasone
03
Conditions
Small for gestational age (SGA)
Beyond the preview
Go deeper on IRCT20250227064870N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250227064870N1.